| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000Ia 4500 |
| 001 |
in00002494875 |
| 005 |
20211202191657.0 |
| 006 |
m d f |
| 007 |
cr an||||||||| |
| 008 |
090521s2004 mdu s f000 0 eng d |
| 035 |
|
|
|a (OCoLC)ocn335221833
|
| 040 |
|
|
|a GPO
|c GPO
|d MvI
|d UtOrBLW
|
| 049 |
|
|
|a WWW
|
| 074 |
|
|
|a 0499-T-02 (online)
|
| 086 |
0 |
|
|a HE 20.4802:C 93
|
| 245 |
0 |
0 |
|a Guidance for industry and FDA :
|b current good manufacturing practice for combination products.
|
| 246 |
3 |
0 |
|a Current good manufacturing practice for combination products
|
| 264 |
|
1 |
|a Rockville, MD :
|b U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of the Commissioner, Office of Combination Products,
|c [2004]
|
| 300 |
|
|
|a 8 pages :
|b digital, PDF file.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 538 |
|
|
|a Mode of access: Internet at the FDA CBER web site. Address as of 5/21/09: http://www.fda.gov/cber/gdlns/gmpcombo.pdf ; current access is available via PURL.
|
| 500 |
|
|
|a Title from PDF title page (viewed on May 21, 2009).
|
| 500 |
|
|
|a "September 2004."
|
| 500 |
|
|
|a Electronic resource.
|
| 650 |
|
0 |
|a Drug development
|x Government policy
|z United States.
|
| 650 |
|
0 |
|a Chemotherapy, Combination
|z United States.
|
| 710 |
1 |
|
|a United States.
|b Food and Drug Administration.
|b Office of Combination Products.
|
| 856 |
4 |
0 |
|u https://purl.fdlp.gov/GPO/LPS112968
|t 0
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s e2ad82e3-9afc-3a7e-b405-f1e1ad68e3f7
|i 9233aa00-6324-37c9-bf3d-6c8ef5f0cf8c
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|d Available Online
|t 0
|e HE 20.4802:C 93
|h Superintendent of Documents classification
|
| 998 |
f |
f |
|a HE 20.4802:C 93
|t 0
|l Available Online
|